CatalystPit

MBRXMoleculin Biotech, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $0.50 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$9.75M
CountryUSA
RECENT INSIDER TRADES
  • 2026-08-05 · Foster Jonathan P. (Chief Financial Officer) · BUY
  • 2026-08-05 · PICKER DONALD H (Chief Science Officer) · BUY
  • 2026-08-05 · KLEMP WALTER V (CEO and President) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders21
Shares held213,892
Value$613.96K
Percent of shares outstanding1.10%
As of quarter end2026-06-30
RECENT NEWS
  • Moleculin Biotech to present at 2026 Maxim Growth Summit
  • MBRX: Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout
  • Moleculin Biotech secures Mexican patent for lung-targeted annamycin through 2040
  • Moleculin Biotech receives Nasdaq delisting notice for minimum bid price violation
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS